Back to BlackRock, Inc. BlackRock, Inc.

MLYSMLYS
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in MINERALYS THERAPEUTICS INC

BlackRock, Inc. holds 5.9M shares of MLYS (MINERALYS THERAPEUTICS INC), worth $158.8M as of 2026-Q2. The position was increased (+31.4% shares). MLYS represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$158.8M

Current Shares

5.9M

Total Value Change

+$132.5M

Total Shares Change

+3.7M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
5.9M
+31.4%
$158.8M0.0%$26.98
39
2026-Q1
Increased
4.5M
+3.6%
$121.4M0.0%$28.51
31
2025-Q4
Increased
4.3M
+17.9%
$157.1M0.0%$35.50
36
2025-Q3
Increased
3.7M
+18.5%
$139.2M0.0%$39.35
36
2025-Q2
Increased
3.1M
+26.4%
$41.9M0.0%$13.71
36
2025-Q1
Increased
2.5M
+14.6%
$38.9M0.0%$14.66
33
2024-Q4
New
2.1M
-
$26.3M0.0%$12.52
40

Other major holders of MLYS: RA CAPITAL MANAGEMENT, L.P., FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used